Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Improving Prescription Drug Warnings to Promote Patient Comprehension

Improving Prescription Drug Warnings to Promote Patient Comprehension ORIGINAL INVESTIGATION Improving Prescription Drug Warnings to Promote Patient Comprehension Michael S. Wolf, PhD, MPH; Terry C. Davis, PhD; Patrick F. Bass, MD, MPH; Laura M. Curtis, MS; Lee A. Lindquist, MD, MPH; Jennifer A. Webb, MA; Mary V. Bocchini, BS; Stacy Cooper Bailey, MPH; Ruth M. Parker, MD Background: Prior studies have documented a high simplified text icons were more likely to be correctly prevalence of patients who misunderstand prescription interpreted compared with standard labels (simplified text drug warning labels, placing them at risk for medica- − adjusted odds ratio [AOR] = 2.64; 95% confidence in- tion error. We evaluated whether the use of “enhanced terval [CI], 2.00-3.49; simplified text icons − AOR = 3.26; print” drug warnings could improve patient comprehen- 95% CI, 2.46-4.32). Patients’ ability to correctly inter- sion beyond a current standard. pret labels was not significantly different with the inclu- sion of icons (simplified text icons − AOR = 1.23; 95% Methods: An evaluation of enhanced print warning la- CI, 0.90-1.67; P = .20). Low literacy was also an indepen- bels was conducted at 2 academic and 2 community health dent predictor of misinterpretation (AOR, 0.65; 95% CI, primary care clinics in Chicago, Illinois, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Loading next page...
 
/lp/american-medical-association/improving-prescription-drug-warnings-to-promote-patient-comprehension-ky5Pn4GFA2
Publisher
American Medical Association
Copyright
Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinternmed.2009.454
pmid
20065199
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL INVESTIGATION Improving Prescription Drug Warnings to Promote Patient Comprehension Michael S. Wolf, PhD, MPH; Terry C. Davis, PhD; Patrick F. Bass, MD, MPH; Laura M. Curtis, MS; Lee A. Lindquist, MD, MPH; Jennifer A. Webb, MA; Mary V. Bocchini, BS; Stacy Cooper Bailey, MPH; Ruth M. Parker, MD Background: Prior studies have documented a high simplified text icons were more likely to be correctly prevalence of patients who misunderstand prescription interpreted compared with standard labels (simplified text drug warning labels, placing them at risk for medica- − adjusted odds ratio [AOR] = 2.64; 95% confidence in- tion error. We evaluated whether the use of “enhanced terval [CI], 2.00-3.49; simplified text icons − AOR = 3.26; print” drug warnings could improve patient comprehen- 95% CI, 2.46-4.32). Patients’ ability to correctly inter- sion beyond a current standard. pret labels was not significantly different with the inclu- sion of icons (simplified text icons − AOR = 1.23; 95% Methods: An evaluation of enhanced print warning la- CI, 0.90-1.67; P = .20). Low literacy was also an indepen- bels was conducted at 2 academic and 2 community health dent predictor of misinterpretation (AOR, 0.65; 95% CI, primary care clinics in Chicago, Illinois,

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jan 11, 2010

References